Inhibitor of Differentiation/DNA Binding 1 (ID1) Inhibits Etoposide-induced Apoptosis in a C-Jun/c-Fos-dependent Manner

Overview

Journal J Biol Chem

Specialty Biochemistry

Date 2016 Feb 10

PMID 26858249

Citations 23

Authors

Yahui Zhao

Aiping Luo

Sheng Li

Wei Zhang

Hongyan Chen

Yi Li

Fang Ding

Furong Huang

Zhihua Liu

Affiliations

Soon will be listed here.

Abstract

ID1 (inhibitor of differentiation/DNA binding 1) acts an important role in metastasis, tumorigenesis, and maintenance of cell viability. It has been shown that the up-regulation of ID1 is correlated with poor prognosis and the resistance to chemotherapy of human cancers. However, the underlying molecular mechanism remains elusive. Here, we determined for the first time that up-regulating ID1 upon etoposide activation was mediated through AP-1 binding sites within theID1promoter and confirmed that ID1 enhanced cell resistance to DNA damage-induced apoptosis in esophageal squamous cell carcinoma cells. Ablation of c-Jun/c-Fos or ID1 expression enhanced etoposide-mediated apoptosis through increasing activity of caspase 3 and PARP cleavage. Moreover, c-Jun/c-Fos and ID1 were positively correlated in human cancers. More importantly, simultaneous high expression of ID1 and c-Jun or c-Fos was correlated with poor survival in cancer patients. Collectively, we demonstrate the importance of c-Jun/c-Fos-ID1 signaling pathway in chemoresistance of esophageal cancer cells and provide considerable insight into understanding the underlying molecular mechanisms in esophageal squamous cell carcinoma cell biology.

Citing Articles

Estrogen receptor alpha (ERα) regulates PARN-mediated nuclear deadenylation and gene expression in breast cancer cells.

Varriano S, Yu A, Xu Y, Natelson D, Ramadei A, Kleiman F RNA Biol. 2024; 21(1):14-23.

PMID: 39392174 PMC: 11487348. DOI: 10.1080/15476286.2024.2413821.

Autophagy-mediated ID1 turnover dictates chemo-resistant fate in ovarian cancer stem cells.

Phadte P, Bishnu A, Dey P, M M, Mehrotra M, Singh P J Exp Clin Cancer Res. 2024; 43(1):222.

PMID: 39123206 PMC: 11316295. DOI: 10.1186/s13046-024-03147-z.

Systematic analysis of apoptosis-related genes in the prognosis of lung squamous cell carcinoma: a combined single-cell RNA sequencing study.

Zhu P, Yang W, Wang B, Zeng T, Hu Z, Zhang D J Thorac Dis. 2024; 15(12):6946-6966.

PMID: 38249925 PMC: 10797354. DOI: 10.21037/jtd-23-1712.

N6-methyladenosine methylation analysis of long noncoding RNAs and mRNAs in 5-FU-resistant colon cancer cells.

Lai J, Zhou Z, Hu K, Yu H, Su X, Niu X Epigenetics. 2023; 19(1):2298058.

PMID: 38145548 PMC: 10761136. DOI: 10.1080/15592294.2023.2298058.

Utilizing network pharmacology and experimental validation to explore the potential molecular mechanisms of raw in treating esophageal cancer.

Liu Y, Bai Y, Zhang J, Silva-Filho R, Zhu Q, Lei Z J Gastrointest Oncol. 2023; 14(5):2006-2017.

PMID: 37969842 PMC: 10643601. DOI: 10.21037/jgo-23-684.

References

He H, Li S, Chen H, Li L, Xu C, Ding F . 12-O-tetradecanoylphorbol-13-acetate promotes breast cancer cell motility by increasing S100A14 level in a Kruppel-like transcription factor 4 (KLF4)-dependent manner. J Biol Chem. 2014; 289(13):9089-99. PMC: 3979376. DOI: 10.1074/jbc.M113.534271. View

Luo A, Chen H, Ding F, Zhang Y, Wang M, Xiao Z . Small proline-rich repeat protein 3 enhances the sensitivity of esophageal cancer cells in response to DNA damage-induced apoptosis. Mol Oncol. 2013; 7(5):955-67. PMC: 5528455. DOI: 10.1016/j.molonc.2013.05.005. View

Yap W, Zaiden N, Tan Y, Ngoh C, Zhang X, Wong Y . Id1, inhibitor of differentiation, is a key protein mediating anti-tumor responses of gamma-tocotrienol in breast cancer cells. Cancer Lett. 2009; 291(2):187-99. DOI: 10.1016/j.canlet.2009.10.012. View

Boeckx C, Blockx L, Op de Beeck K, Limame R, Van Camp G, Peeters M . Establishment and characterization of cetuximab resistant head and neck squamous cell carcinoma cell lines: focus on the contribution of the AP-1 transcription factor. Am J Cancer Res. 2015; 5(6):1921-38. PMC: 4529614. View

Liu J, Hu Y, Hu W, Xie X, Bella A, Fu J . Expression and prognostic relevance of Id1 in stage III esophageal squamous cell carcinoma. Cancer Biomark. 2011; 8(2):67-72. DOI: 10.3233/DMA-2011-0831. View

Subramanian D, Bunjobpol W, Sabapathy K . Interplay between TAp73 Protein and Selected Activator Protein-1 (AP-1) Family Members Promotes AP-1 Target Gene Activation and Cellular Growth. J Biol Chem. 2015; 290(30):18636-49. PMC: 4513121. DOI: 10.1074/jbc.M115.636548. View

Zhang X, Huang X, Olumi A . Repression of NF-kappaB and activation of AP-1 enhance apoptosis in prostate cancer cells. Int J Cancer. 2009; 124(8):1980-9. PMC: 2715938. DOI: 10.1002/ijc.24139. View

Shaulian E, Karin M . AP-1 as a regulator of cell life and death. Nat Cell Biol. 2002; 4(5):E131-6. DOI: 10.1038/ncb0502-e131. View

Yang H, Li X, Zhou Y, Ban X, Zeng T, Li L . Stemness and chemotherapeutic drug resistance induced by EIF5A2 overexpression in esophageal squamous cell carcinoma. Oncotarget. 2015; 6(28):26079-89. PMC: 4694887. DOI: 10.18632/oncotarget.4581. View

10.

He H, Li S, Hong Y, Zou H, Chen H, Ding F . Krüppel-like Factor 4 Promotes Esophageal Squamous Cell Carcinoma Differentiation by Up-regulating Keratin 13 Expression. J Biol Chem. 2015; 290(21):13567-77. PMC: 4505602. DOI: 10.1074/jbc.M114.629717. View

11.

Goswami C, Nakshatri H . PROGgeneV2: enhancements on the existing database. BMC Cancer. 2014; 14:970. PMC: 4300843. DOI: 10.1186/1471-2407-14-970. View

12.

Zhang S, Tang W, Weng S, Liu X, Rao B, Gu J . Apollon modulates chemosensitivity in human esophageal squamous cell carcinoma. Oncotarget. 2014; 5(16):7183-97. PMC: 4196194. DOI: 10.18632/oncotarget.2293. View

13.

Lasorella A, Benezra R, Iavarone A . The ID proteins: master regulators of cancer stem cells and tumour aggressiveness. Nat Rev Cancer. 2014; 14(2):77-91. DOI: 10.1038/nrc3638. View

14.

Li S, Zhou Q, He H, Zhao Y, Liu Z . Peroxisome proliferator-activated receptor γ agonists induce cell cycle arrest through transcriptional regulation of Kruppel-like factor 4 (KLF4). J Biol Chem. 2013; 288(6):4076-84. PMC: 3567659. DOI: 10.1074/jbc.M111.317487. View

15.

Yu X, Luo A, Zhou C, Ding F, Wu M, Zhan Q . Differentiation-associated genes regulated by TPA-induced c-Jun expression via a PKC/JNK pathway in KYSE450 cells. Biochem Biophys Res Commun. 2006; 342(1):286-92. DOI: 10.1016/j.bbrc.2006.01.147. View

16.

OBrien C, Kreso A, Ryan P, Hermans K, Gibson L, Wang Y . ID1 and ID3 regulate the self-renewal capacity of human colon cancer-initiating cells through p21. Cancer Cell. 2012; 21(6):777-92. DOI: 10.1016/j.ccr.2012.04.036. View

17.

Birkenkamp K, Essafi A, van der Vos K, da Costa M, Hui R, Holstege F . FOXO3a induces differentiation of Bcr-Abl-transformed cells through transcriptional down-regulation of Id1. J Biol Chem. 2006; 282(4):2211-20. DOI: 10.1074/jbc.M606669200. View

18.

McNeely S, Xu X, Taylor B, Zacharias W, McCabe Jr M, States J . Exit from arsenite-induced mitotic arrest is p53 dependent. Environ Health Perspect. 2006; 114(9):1401-6. PMC: 1570045. DOI: 10.1289/ehp.8969. View

19.

Shimada Y, Imamura M, Wagata T, Yamaguchi N, Tobe T . Characterization of 21 newly established esophageal cancer cell lines. Cancer. 1992; 69(2):277-84. DOI: 10.1002/1097-0142(19920115)69:2<277::aid-cncr2820690202>3.0.co;2-c. View

20.

Ling F, Kang B, Sun X . Id proteins: small molecules, mighty regulators. Curr Top Dev Biol. 2014; 110:189-216. DOI: 10.1016/B978-0-12-405943-6.00005-1. View